Skip to main content

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders) was previously published as Current Drug Targets-CNS & Neurological Disorders.

Publisher: Bentham Science Publishers

Volume 9, Number 1, March 2010

Articles

Commentary [Research Highlights]
pp. 1-1(1)
Author: Skaper, Stephen D.

Favourites:
ADD

Disulfiram: An Old Therapeutic with New Applications
pp. 5-12(8)
Authors: Barth, Kelly S.; Malcolm, Robert J.

Favourites:
ADD

Naltrexone for the Treatment of Alcoholism: Clinical Findings, Mechanisms of Action, and Pharmacogenetics
pp. 13-22(10)
Authors: Ray, Lara A.; Chin, Pauline F.; Miotto, Karen

Favourites:
ADD

Acamprosate: A Prototypic Neuromodulator in the Treatment of Alcohol Dependence
pp. 23-32(10)
Authors: Mason, Barbara J.; Heyser, Charles J.

Favourites:
ADD

Effectiveness and Safety of Baclofen in the Treatment of Alcohol Dependent Patients
pp. 33-44(12)
Authors: Leggio, Lorenzo; Garbutt, James C.; Addolorato, Giovanni

Favourites:
ADD
Favourites:
ADD

Blockade of the Cannabinoid CB1 Receptor and Alcohol Dependence: Preclinical Evidence and Preliminary Clinical Data
pp. 55-59(5)
Authors: Maccioni, Paola; Colombo, Giancarlo; Carai, Mauro A.M.

Favourites:
ADD
Favourites:
ADD

Free Content TRPC Channels and their Implications for Neurological Diseases
pp. 94-104(11)
Authors: Selvaraj, Senthil; Sun, Yuyang; Singh, Brij B.

Favourites:
ADD

Mitochondrial Metabolism Modulation: A New Therapeutic Approach for Parkinson's Disease
pp. 105-119(15)
Authors: Arduino, D. M.; Esteves, A. R.; Oliveira, C. R.; Cardoso, S. M.

Favourites:
ADD

Raf Inhibitors as Therapeutic Agents Against Neurodegenerative Diseases
pp. 120-127(8)
Authors: Burgess, Sarah; Echeverria, Valentina

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more